Lidocaine: cough (fentanyl induced)

Area of Science:

• Pharmacy
• Pharmacology
• Clinical Practice

Background:

• Off-label drug use refers to applications not approved by the US Food and Drug Administration (FDA).
• Practitioners require reliable information on these unapproved uses for informed patient care.
• Existing resources may not adequately address the need for curated literature on off-label drug applications.

Purpose of the Study:

• To introduce a practitioner-oriented resource for off-label drug information.
• To enable healthcare professionals to quickly identify relevant literature on unapproved drug uses.
• To assist clinicians in assessing the rationality of off-label drug applications in patient care.

Main Methods:

• Extraction of information from the publication 'Off-Label Drug Facts'.
• Focus on literature identifying and evaluating specific off-label drug uses.
• Provision of references for comprehensive information access.

Main Results:

• A new guide is available for healthcare professionals.
• The guide facilitates rapid identification of published studies on off-label drug uses.
• It supports the determination of whether a specific off-label use is rational.

Conclusions:

• 'Off-Label Drug Facts' serves as a valuable resource for clinicians.
• The guide enhances evidence-based decision-making for unapproved drug applications.
• It promotes rational and informed patient care concerning off-label drug use.